Drugs used to treat cancer, diabetes and other chronic conditions are among 15 picked for negotiations that could result in lower prices for patients, the Department of Health and Human Services confirmed Friday.
The 15 drugs selected by HHS are all covered under Medicare Part D and represent the second round of negotiations between drug companies and the department, with a goal of lowering costs for Medicare patients.
Popular diabetes drugs Ozempic, Rybelsus and Wegovy, which are also used for weight loss are among the 15 announced Friday.
Source: Latest Medicare price drug negotiations includes Ozempic, Wegovy – UPI.com







You must be logged in to post a comment.